Day: June 18, 2020

EINDHOVEN, The Netherlands, June 18, 2020 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) today announced HoverGames Challenge 2: Help Drones Help Others. The second installment of NXP’s challenge-based, interactive coding competition encourages developers to create drone and rover solutions for frontline support during pandemics. Participants will leverage NXP’s broad portfolio of automotive, industrial and IOT technologies for system control, networking, security and motor control to create solutions that can make a difference in pandemic response.The collateral effects of pandemics leave citizens with difficult challenges to overcome.  A lack of mobility, social isolation and lack of access to goods and services can be physically and psychologically devastating. HoverGames Challenge 2 will inspire participants to develop...

Saint-Herblain, France, June 18, 2020 – Valneva SE, (“Valneva”), a specialty vaccine company, and Bavarian Nordic A/S (OMX: BAVA) today announced that they have signed a binding term sheet to establish a partnership for the marketing and distribution of their commercial products. The partnership will provide both companies with additional critical mass, significant commercial synergies and a market leadership position in the specialty vaccine industry.Under the agreed terms, Valneva will commercialize Bavarian Nordic’s marketed vaccines leveraging its commercial infrastructure in Canada, UK, France and Austria. Valneva will also take responsibility for Belgium and the Netherlands where it will set up new commercial operations. Bavarian Nordic will commercialize Valneva’s marketed products in Germany and Switzerland. The partnership includes...

Saint-Herblain, France, 18 juin 2020 – Valneva SE, (“Valneva”), société spécialisée dans les vaccins et Bavarian Nordic A/S (OMX: BAVA) ont annoncé aujourd’hui la signature d’une lettre d’intention liante (binding term sheet) destinée à former un partenariat entre les deux sociétés pour le marketing et la distribution de leurs produits commerciaux. Le partenariat apportera aux deux entreprises davantage de masse critique, des synergies commerciales importantes et une position de leader sur le marché des vaccins spécialisés.Selon les termes convenus entre les deux sociétés, Valneva commercialisera les vaccins de Bavarian Nordic en s’appuyant sur son infrastructure commerciale au Canada, en Grande-Bretagne, en France et en Autriche. Valneva les commercialisera également en Belgique et aux Pays-Bas, où une infrastructure commerciale sera...

COPENHAGEN, Denmark, June 18, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) and Valneva SE today announced a partnership for the marketing and distribution of their commercial products. The companies have signed a term sheet outlining a mutual agreement, which will create significant commercial synergies and a market leadership position in the specialty vaccine industry.Leveraging its existing global marketing and distribution network, Valneva will assume responsibility for the marketing and distribution of Bavarian Nordic’s vaccines for rabies and tick-borne encephalitis in selected European countries and Canada. Starting in the second half of 2020, product distribution will be transferred directly to Valneva as part of the overall transition plan agreed upon Bavarian Nordic’s recent acquisition of these products from GlaxoSmithKline.Bavarian...

KØBENHAVN, Danmark, 18. juni 2020 – Bavarian Nordic A/S (OMX: BAVA) og Valneva SE annoncerede i dag indgåelsen af et partnerskab om markedsføring og distribution af deres kommercielle produkter. Virksomhederne har underskrevet en rammeaftale, der skitserer en gensidig aftale, som vil skabe betydelige kommercielle synergier og en markedsledende position inden for specialvacciner.Via udnyttelsen af sit eksisterende globale marketing- og distributionsnetværk vil Valneva overtage ansvaret for marketing og distribution af Bavarian Nordics vacciner mod rabies og flåtbåren hjernebetændelse (TBE) i udvalgte europæiske lande samt Canada. Med start i andet halvår 2020 vil distributionen blive overført direkte til Valneva, som led i den samlede plan for overtagelsen af produkterne efter det nylige køb af disse fra GlaxoSmithKline (GSK).Senere på...

Schibsted ASA has granted restricted B-shares to key employees in connection with the long-term incentive plan (the “LTI Plan”) which will be transferred to participants at the end of the 3-year program period. The LTI Plan is an annual 3-year rolling plan, part delivered in restricted shares and part delivered in performance shares, with fulfilment in Schibsted B-shares. The program is applicable to the CEO, members of Schibsted’s Group Management Team, members of management teams in the business areas Nordic Marketplaces, News Media, and Next, as well as other key employees. For more information on the LTI Plan, please refer to Schibsted ASA’s annual report 2019 under the section “The Board of Directors’ Statement of Executive Compensation for Schibsted excluding Adevinta”.Please find attached overview of the net number of restricted...

IMpassion031 data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines AgencyTecentriq is the only approved cancer immunotherapy for the treatment of metastatic triple-negative breast cancer, a very aggressive and difficult-to-treat form of breast cancerBasel, 18 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpassion031 study, evaluating Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel; followed by doxorubicin and cyclophosphamide) in comparison to placebo plus chemotherapy (including Abraxane), met its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in pathological complete response (pCR) for the treatment of people...

WISeKey Appoints Danil Kerimi to its Advisory Committee to assist the Company’s Digital Transformation

Investors House Oyj                                                                          Lehdistötiedote 18.6.2020 klo 8.00INVESTORS HOUSE KIINTEISTÖVARALLISUUDENHOITO: ASUNTOVUOKRAUS HYYTYI JA HILJAISELO JATKUUInvestors Housen Kiinteistövarallisuudenhoito -yksikön asuntovuokrausmäärä laski 354 kappaleeseen (419 kpl). Lasku – 16 % on seurantahistorian suurin. Vuokrausmäärät supistuivat kaikilla toimintapaikkakunnilla pois lukien Joensuu. Kokonaispalvelu kohteiden määrä 2785 kpl (1938 kpl).’’Asuntovuokraus hyytyi toukokuussa. Sama hiljaiselo on jatkunut kesäkuussa. Ihmiset ovat varovaisia muuttamaan tällä hetkellä. Monilla paikkakunnilla on myös rakennettu kysyntään nähden liikaa uusia vuokra-asuntoja’’, sanoo Marita Polvi-Lohikoski.Asuntovuokrausta ja Kokonaispalvelua Investors Housen Kiinteistövarallisuudenhoidon yksikössä tekee...